Yizhi Zhan

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Prognostic Factors

Patient Reported Outcomes

Ejection Fraction

Top Venues

British journal of cancer

Cell death & disease

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Yuechen Liu, Zhenkang Li, Jinchao Zhang, Wei Liu, Shenyuan Guan, Yizhi Zhan, Yuan Fang, Yong-Sheng Li, Haijun Deng, Zhiyong Shen
DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity. British journal of cancer 131 (2) (2024)
Yuechen Liu, Zhenkang Li, Jinchao Zhang, Wei Liu, Shenyuan Guan, Yizhi Zhan, Yuan Fang, Yong-Sheng Li, Haijun Deng, Zhiyong Shen
DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity. British journal of cancer (2024)
Yuechen Liu, Zhenkang Li, Jinchao Zhang, Wei Liu, Shenyuan Guan, Yizhi Zhan, Yuan Fang, Yong-Sheng Li, Haijun Deng, Zhiyong Shen
DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity. British journal of cancer 131 (2) (2024)
Yuechen Liu, Zhenkang Li, Jinchao Zhang, Wei Liu, Shenyuan Guan, Yizhi Zhan, Yuan Fang, Yong-Sheng Li, Haijun Deng, Zhiyong Shen
DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity. British journal of cancer 131 (2) (2024)
Yuechen Liu, Zhenkang Li, Jinchao Zhang, Wei Liu, Shenyuan Guan, Yizhi Zhan, Yuan Fang, Yong-Sheng Li, Haijun Deng, Zhiyong Shen
DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity. British journal of cancer 131 (2) (2024)
Yuechen Liu, Zhenkang Li, Jinchao Zhang, Wei Liu, Shenyuan Guan, Yizhi Zhan, Yuan Fang, Yong-Sheng Li, Haijun Deng, Zhiyong Shen
DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity. British journal of cancer 131 (2) (2024)
Yilin Zheng, Yizhi Zhan, Yuqin Zhang, Yaowei Zhang, Yang Liu, Yuwen Xie, Yining Sun, Junying Qian, Yan-Qing Ding, Yi Ding, Yuan Fang
Hexokinase 2 confers radio-resistance in hepatocellular carcinoma by promoting autophagy-dependent degradation of AIMP2. Cell death & disease 14 (8) (2023)
Yongjia Wang, Yuqin Zhang, Zixuan Wang, Lu Yu, Keli Chen, Yuwen Xie, Yang Liu, Weijie Liang, Yilin Zheng, Yizhi Zhan, Yi Ding
The interplay of transcriptional coregulator NUPR1 with SREBP1 promotes hepatocellular carcinoma progression via upregulation of lipogenesis. Cell death discovery 8 (1) (2022)
Yizhi Zhan, Zhanqiao Zhang, Yuechen Liu, Yuan Fang, Yuwen Xie, Yilin Zheng, Guoxin Li, Li Liang, Yi Ding
NUPR1 contributes to radiation resistance by maintaining ROS homeostasis via AhR/CYP signal axis in hepatocellular carcinoma. BMC medicine 20 (1) (2022)
Zhiyong Shen, Xiaochuang Feng, Yuan Fang, Yongsheng Li, Zhenkang Li, Yizhi Zhan, Mingdao Lin, Guoxin Li, Yi Ding, Haijun Deng
POTEE drives colorectal cancer development via regulating SPHK1/p65 signaling. Cell death & disease 10 (11) (2019)